-
Je něco špatně v tomto záznamu ?
Comparison of Active Substance Losses and Total Weight Losses of Tablets Administered Via Feeding Tube
A. Papiez, K. Odehnalova, V. Sramek, P. Suk,
Jazyk angličtina Země Švýcarsko
Typ dokumentu srovnávací studie, zprávy, validační studie
PubMed
30726848
DOI
10.1159/000496423
Knihovny.cz E-zdroje
- MeSH
- enterální výživa přístrojové vybavení MeSH
- enterosolventní tablety MeSH
- gastrointestinální intubace * MeSH
- klopidogrel aplikace a dávkování chemie MeSH
- pantoprazol aplikace a dávkování chemie MeSH
- spektrofotometrie ultrafialová metody MeSH
- tablety MeSH
- vysokoúčinná kapalinová chromatografie metody MeSH
- Publikační typ
- srovnávací studie MeSH
- validační studie MeSH
- zprávy MeSH
BACKGROUND/AIMS: Administration of tablets via feeding tube (FT) is often associated with significant drug losses, as was confirmed by weighing. The aim of this study was to measure the proportion of active substance losses (ASLs) in an in vitro model. METHODS: A film-coated tablet (FilmCT) containing clopidogrel (Trombex®) and a tablet with enteric coating (EntericCT) containing pantoprazole (Controloc®) were crushed in a mortar and transferred by method A (tablet powder was transferred into the beaker, poured into the syringe and water added) and method B (water was added into the mortar, suspension drawn into the syringe) and administered via FT in an in vitro model. Total losses were measured with analytical balance and, simultaneously, ASL were analyzed with high-performance liquid chromatography UV-detection (HPLC-UV). RESULTS: ASL was different to weighing only in the case of EntericCT prepared by method B (2.0 ± 4.2 and 10.7 ± 0.8% for HPLC-UV and weighing, respectively; p = 0.004). HPLC-UV confirmed significantly lower ASL when method B was used for either EntericCT (34.3 ± 7.2 vs. 2.0 ± 4.2%; p < 0.001) or FilmCT (14.1 ± 2.2 vs. 7.7 ± 4.1%; p < 0.01). CONCLUSION: Drug loss analysis with analytical balance may overestimate ASL, as was proved for EntericCT in this study. ASL were significantly lower when method B was used.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19027847
- 003
- CZ-PrNML
- 005
- 20190822091531.0
- 007
- ta
- 008
- 190813s2019 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1159/000496423 $2 doi
- 035 __
- $a (PubMed)30726848
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Papiez, Adriana $u Clinical Pharmacology Unit, Department of Anaesthesia and Intensive Care, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic. Faculty of Medicine, Masaryk University, Brno, Czech Republic.
- 245 10
- $a Comparison of Active Substance Losses and Total Weight Losses of Tablets Administered Via Feeding Tube / $c A. Papiez, K. Odehnalova, V. Sramek, P. Suk,
- 520 9_
- $a BACKGROUND/AIMS: Administration of tablets via feeding tube (FT) is often associated with significant drug losses, as was confirmed by weighing. The aim of this study was to measure the proportion of active substance losses (ASLs) in an in vitro model. METHODS: A film-coated tablet (FilmCT) containing clopidogrel (Trombex®) and a tablet with enteric coating (EntericCT) containing pantoprazole (Controloc®) were crushed in a mortar and transferred by method A (tablet powder was transferred into the beaker, poured into the syringe and water added) and method B (water was added into the mortar, suspension drawn into the syringe) and administered via FT in an in vitro model. Total losses were measured with analytical balance and, simultaneously, ASL were analyzed with high-performance liquid chromatography UV-detection (HPLC-UV). RESULTS: ASL was different to weighing only in the case of EntericCT prepared by method B (2.0 ± 4.2 and 10.7 ± 0.8% for HPLC-UV and weighing, respectively; p = 0.004). HPLC-UV confirmed significantly lower ASL when method B was used for either EntericCT (34.3 ± 7.2 vs. 2.0 ± 4.2%; p < 0.001) or FilmCT (14.1 ± 2.2 vs. 7.7 ± 4.1%; p < 0.01). CONCLUSION: Drug loss analysis with analytical balance may overestimate ASL, as was proved for EntericCT in this study. ASL were significantly lower when method B was used.
- 650 _2
- $a vysokoúčinná kapalinová chromatografie $x metody $7 D002851
- 650 _2
- $a klopidogrel $x aplikace a dávkování $x chemie $7 D000077144
- 650 _2
- $a enterální výživa $x přístrojové vybavení $7 D004750
- 650 12
- $a gastrointestinální intubace $7 D007441
- 650 _2
- $a pantoprazol $x aplikace a dávkování $x chemie $7 D000077402
- 650 _2
- $a spektrofotometrie ultrafialová $x metody $7 D013056
- 650 _2
- $a tablety $7 D013607
- 650 _2
- $a enterosolventní tablety $7 D013608
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a zprávy $7 D016433
- 655 _2
- $a validační studie $7 D023361
- 700 1_
- $a Odehnalova, Klara $u Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic.
- 700 1_
- $a Sramek, Vladimir $u Clinical Pharmacology Unit, Department of Anaesthesia and Intensive Care, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic. Faculty of Medicine, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Suk, Pavel $u Clinical Pharmacology Unit, Department of Anaesthesia and Intensive Care, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic, pavel.suk@fnusa.cz. Faculty of Medicine, Masaryk University, Brno, Czech Republic, pavel.suk@fnusa.cz.
- 773 0_
- $w MED00003791 $t Pharmacology $x 1423-0313 $g Roč. 103, č. 5-6 (2019), s. 246-249
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30726848 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190822091809 $b ABA008
- 999 __
- $a ok $b bmc $g 1432996 $s 1066307
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 103 $c 5-6 $d 246-249 $e 20190206 $i 1423-0313 $m Pharmacology $n Pharmacology $x MED00003791
- LZP __
- $a Pubmed-20190813